CH628637A5 - Derives de la neocarzinostatine et procede pour leur preparation. - Google Patents

Derives de la neocarzinostatine et procede pour leur preparation. Download PDF

Info

Publication number
CH628637A5
CH628637A5 CH324578A CH324578A CH628637A5 CH 628637 A5 CH628637 A5 CH 628637A5 CH 324578 A CH324578 A CH 324578A CH 324578 A CH324578 A CH 324578A CH 628637 A5 CH628637 A5 CH 628637A5
Authority
CH
Switzerland
Prior art keywords
neocarzinostatin
fraction
derivatives
molecular weight
residue
Prior art date
Application number
CH324578A
Other languages
English (en)
French (fr)
Inventor
Hiroshi Maeda
Ryunosuke Kanamaru
Nakao Ishida
Original Assignee
Ryunosuke Kanamaru
Kayaku Antibiotic Research Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ryunosuke Kanamaru, Kayaku Antibiotic Research Co filed Critical Ryunosuke Kanamaru
Publication of CH628637A5 publication Critical patent/CH628637A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S260/00—Chemistry of carbon compounds
    • Y10S260/47—Poisons, foods, or pharmaceuticals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
CH324578A 1977-03-24 1978-03-23 Derives de la neocarzinostatine et procede pour leur preparation. CH628637A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52032412A JPS6017206B2 (ja) 1977-03-24 1977-03-24 ネオカルチノスタチン誘導体の製造法

Publications (1)

Publication Number Publication Date
CH628637A5 true CH628637A5 (fr) 1982-03-15

Family

ID=12358227

Family Applications (1)

Application Number Title Priority Date Filing Date
CH324578A CH628637A5 (fr) 1977-03-24 1978-03-23 Derives de la neocarzinostatine et procede pour leur preparation.

Country Status (6)

Country Link
US (1) US4182752A (cg-RX-API-DMAC7.html)
JP (1) JPS6017206B2 (cg-RX-API-DMAC7.html)
CH (1) CH628637A5 (cg-RX-API-DMAC7.html)
DE (1) DE2813017A1 (cg-RX-API-DMAC7.html)
FR (1) FR2384811A1 (cg-RX-API-DMAC7.html)
GB (1) GB1565794A (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3367921D1 (en) * 1982-02-27 1987-01-15 Kuraray Co Neocarzinostatin complexes, a method for producing the same, and an antitumor agent containing said complexes as an active component
JPS58149903A (ja) * 1982-02-27 1983-09-06 Kuraray Co Ltd ネオカルチノスタチン複合体の製造法
JPS59139396A (ja) * 1983-01-31 1984-08-10 Kuraray Co Ltd ネオカルチノスタチン複合体の製造方法
US4604221A (en) * 1982-07-06 1986-08-05 The Lubrizol Corporation Nitrogen-containing esters and lubricants containing them
JPS6075432A (ja) * 1983-08-08 1985-04-27 Kuraray Co Ltd ネオカルチノスタチン誘導体及びその製造方法
JPS6075499A (ja) * 1983-08-08 1985-04-27 Kuraray Co Ltd ネオカルチノスタチン誘導体及びその製造法
US4594378A (en) * 1985-03-25 1986-06-10 The Lubrizol Corporation Polymeric compositions, oil compositions containing said polymeric compositions, transmission fluids and hydraulic fluids
JPS63211238A (ja) * 1987-02-27 1988-09-02 Masayasu Inoue 抗潰瘍剤
US5389366A (en) * 1986-09-19 1995-02-14 Yamanouchi Pharmaceutical Co., Ltd. Neocarzinostatin derivative composition for oral administration
JP2556865B2 (ja) * 1986-09-19 1996-11-27 山之内製薬株式会社 ネオカルチノスタチン誘導体の非注射投与用組成物
CA1327161C (en) * 1987-09-01 1994-02-22 Mitsugu Kobayashi Lyophilized pharmaceutical composition of neocarzinostatin derivative
US5001112A (en) * 1988-04-12 1991-03-19 Bristol-Myers Company Antitumor antibiotic kedarcidin
FR2688788B1 (fr) * 1992-03-17 1994-05-13 Bio Merieux Composes hydrosolubles derives d'un homopolymere ou copolymere de l'anhydride maleique, et applications desdits composes au support de molecules biologiques.
WO2001003738A1 (fr) * 1999-07-07 2001-01-18 Hiroshi Maeda Agents de type polymeres destines a la prevention de metastases et de la recurrence du cancer et methode de prevention de metastases et de la recurrence du cancer
GB0123232D0 (en) * 2001-09-26 2001-11-21 Smith & Nephew Polymers
JPWO2006112362A1 (ja) * 2005-04-18 2008-12-11 前田 浩 高分子型癌治療用医薬の製造方法
EP3072910A4 (en) * 2013-11-19 2018-02-21 Hiroshi Maeda Derivative of styrene-maleic acid copolymer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121043A (en) * 1960-05-11 1964-02-11 Scient Associates Inc Sustained release pharmaceutical preparation and methods for making same
US3334022A (en) * 1965-04-26 1967-08-01 Room 605 Empire Corp Neocarzinostatin produced by streptomyces carzinost aticus var. neocarzinostaticus

Also Published As

Publication number Publication date
JPS6017206B2 (ja) 1985-05-01
DE2813017C2 (cg-RX-API-DMAC7.html) 1988-02-25
DE2813017A1 (de) 1978-10-05
US4182752A (en) 1980-01-08
GB1565794A (en) 1980-04-23
FR2384811A1 (fr) 1978-10-20
FR2384811B1 (cg-RX-API-DMAC7.html) 1982-11-19
JPS53117095A (en) 1978-10-13

Similar Documents

Publication Publication Date Title
EP0275748B1 (fr) Nouveaux dérivés peptidiques et leur application notamment en thérapeutique
DE3786250T2 (de) Phosphinsäure-Derivate.
US5118665A (en) Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
CN110240629B (zh) 蛋白降解靶向bcr-abl化合物及其抗肿瘤应用
FR2757521A1 (fr) Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2677361A1 (fr) Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US4182752A (en) Neocarzinostatin derivatives and a process for producing the same
EP0049666A1 (fr) Nouvelles substances biologiquement actives, leur obtention à partir de caséine humaine et compositions les contenant
EP0316322B1 (fr) Tetrapeptide inhibiteur de l'entree en cycle des cellules souches hematopo etiques, procedes pour son obtention et ses applications
EP0316408A1 (en) Method of tumor inhibition in warm-blooded animals
AU2003298077A1 (en) Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours
CH661661A5 (fr) Agent antineoplasique.
EP0052028B1 (fr) Nouveaux hexapeptides, leur préparation, leur application comme médicaments et les compositions les renfermant
US20200261534A1 (en) New treatments of multiple myeloma
JPS58203982A (ja) ビタミンe−アミノ酸エステル類およびその製造方法
FR2531952A1 (fr) Analogues a forte activite gonadotrope du facteur liberant l'hormone luteinisante et l'hormone folliculostimulante et leur procede de preparation
LU83822A1 (fr) Derives n-(vinblastinoyl-23)d'acides amines,leur preparation et leur application therapeutique
EP0036420A1 (fr) Peptides ayant des poprietes immunostimulantes et compositions pharmaceutiques les contenant.
LU81968A1 (fr) Sels d'argent d'acide phosphanilique,leur procede de production,composition antibacterienne les contenant et leur application a l'inhibition de la croissance des bacteries
LU84095A1 (fr) Sels d'acetylcysteine,leur preparation et leur utilisation
EP0155199B1 (fr) Nouvel héxapeptide,son procédé d'obtention et les compositions pharmaceutiques qui le contiennent
EP0315519B1 (fr) Nouveaux dérivés de l'acide aminopimélique, leur procédé de préparation et leur application comme médicaments
EP0394135A1 (fr) Noveaux dérivés macrolides, leur procédé de préparation et leur compositions pharmaceutiques qui les contiennent
CH417852A (fr) Procédé de préparation d'un antigène staphylococcique
HU202546B (en) Process for producing peptiodglycan monomer n-acyl derivatives and pharmaceutical compositions comprising same as active ingredient

Legal Events

Date Code Title Description
PUE Assignment

Owner name: YAMANOUCHI PHARMACEUTICAL CO., LTD.

PFA Name/firm changed

Owner name: KAYAKU CO., LTD

PL Patent ceased